Soare et al. [64] recently found that pharmacological inhibition of DPP-4 promoted regression of bleomycin-induced dermal thickness in murine models of systemic sclerosis, and DPP4-knockout mice were less susceptible to bleomycin-induced dermal and pulmonary fibrosis. This evidence concerns the gene DPP4 and systemic sclerosis.